← Back to directory
SB
Sound Bioventures
Malmö, SwedenWebsite ↗
Sound Bioventures is a venture capital fund investing in about-to-be clinical and clinical-stage private companies in Europe and the USA, developing novel medicines that address unmet medical needs. They focus on specialty therapeutics and orphan/rare disease opportunities.
Last raised
Jan 2026
6 mo ago
Latest fund size
$21.6M
Sound Bioventures Fund II
AUM
—
Funds raised
Capital this firm has raised, newest first
Sound Bioventures Fund II
Jan 2026
$21.6M
Sound Bioventures Fund I
Jan 2023
$125.3M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Cytospire Therapeutics | Series A | $83M | May 2026 | |
| BOOST Pharma | — | — | Nov 2025 | |
| Arthex Biotech | — | — | Sep 2025 | |
| AnaCardioLead | Series A | $19M | Dec 2024 | |
| NephroDI TherapeuticsLead | Series A | $4M | Jun 2024 | |
| Theolytics | — | $24.5M | Apr 2024 | |
| AbolerIS Pharma | — | — | Aug 2023 | |
| VarmX | — | — | May 2023 |
Sources
Where this data came from